Clinical Research Directory
Browse clinical research sites, groups, and studies.
Role of FDG PET/CT in Patients With Metastasis of Unknown Origin
Sponsor: Assiut University
Summary
Evaluatation of the role of F18FDG-PET/CT in patients with metastases of unknown origin.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
73
Start Date
2023-10
Completion Date
2026-12
Last Updated
2023-09-28
Healthy Volunteers
Not specified
Conditions
Interventions
PET/CT
Patient preparation: Patients will fast for 4 - 6 h before PET scanning to optimize the blood sugar level to 160mg/dl. F-18 FDG dose was 0.14 mCi/kg and injected via intravenous route. During the uptake phase of 18F-FDG patients will be rested in a quite warm room. Procedure: All PET-CT studies will be done at the nuclear medicine unit in Assuit University Hospital. PET-CT images will be interpreted at a workstation equipped with fusion software that offers multi-planar reformatted images and enables display of the PET images, CT images, and fused PET/CT images.